Comment
Author: Admin | 2025-04-28
The onset or exacerbation of motor and verbal tics. Worsening of Tourette’s syndrome has also been reported. Before initiating Adderall®, assess the family history and clinically evaluate patients for tics or Tourette’s syndrome. Regularly monitor patients for the emergence or worsening of tics or Tourette’s syndrome with Adderall®, and discontinue treatment if clinically appropriate. Precautions Information for Patients Advise the patient to read the FDA-approved patient labeling (Medication Guide). Abuse, Misuse, and Addiction Educate patients and their families about the risks of abuse, misuse, and addiction of Adderall®, which can lead to overdose and death, and proper disposal of any unused drug [see WARNINGS, DRUG ABUSE AND DEPENDENCE, OVERDOSAGE]. Advise patients to store Adderall® in a safe place, preferably locked, and instruct patients to not give Adderall® to anyone else. Risks to Patients with Serious Cardiac Disease Advise patients that there are potential risks to patients with serious cardiac disease, including sudden death, with Adderall® use. Instruct patients to contact a healthcare provider immediately if they develop symptoms such as exertional chest pain, unexplained syncope, or other symptoms suggestive of cardiac disease [see WARNINGS]. Increased Blood Pressure and Heart Rate Advise patients that Adderall® can elevate blood pressure and heart rate [see WARNINGS]. Psychiatric Adverse Reactions Advise patients that Adderall®, at recommended doses, can cause psychotic or manic symptoms, even in patients without prior history of psychotic symptoms or mania [see WARNINGS]. Long-Term Suppression of Growth in Pediatric Patients Advise patients that Adderall® may cause slowing of growth including weight
Add Comment